Welcome to our dedicated page for Runway Growth Finance SEC filings (Ticker: RWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Runway Growth Finance Corp. (Nasdaq: RWAY), a Maryland-incorporated specialty finance company that operates as a closed-end investment fund and has elected to be regulated as a business development company under the Investment Company Act of 1940. Through these filings, investors can review the company’s regulatory disclosures about its investment portfolio, capital structure, and material corporate events.
Runway Growth Finance files periodic reports such as Forms 10-K and 10-Q, which describe its portfolio of loans and equity-related investments, sector exposures in areas like technology and healthcare, use of leverage, and risk factors. Current reports on Form 8-K, several of which are referenced in the data above, disclose items including quarterly financial results, dividend declarations, portfolio activity, and the entry into a definitive merger agreement to acquire SWK Holdings Corporation, a life science focused specialty finance company.
On this page, users can also find filings related to Runway Growth Finance’s notes due 2027, its status as an emerging growth company, and other capital markets information. Items filed under Regulation FD and other events provide additional context on portfolio updates, conference calls, and transaction announcements. Together, these documents form the primary source of official information about RWAY’s operations, governance, and financial condition.
Stock Titan enhances access to these filings with tools that surface key items such as quarterly and annual reports, material 8-K disclosures, and documents related to significant transactions. This allows readers to review Runway Growth Finance’s SEC reports alongside other market data when evaluating the company.
Runway Growth Finance Corp. completed its acquisition of SWK Holdings Corporation, converting each SWK share into 1.7264 Runway Growth shares or $20.59 in cash, plus $0.74 in cash funded by the adviser. The company issued about 6,330,640 new shares.
The final purchase price was $249.0 million, consisting of $75.5 million in Runway Growth stock and $173.5 million in cash, with an additional $9.0 million cash contribution from the external adviser. Runway Growth also assumed $30,000,000 of SWK’s 9.00% Senior Notes due 2027.
On a pro forma basis, the deal expands Runway Growth’s balance sheet to $1.2 billion in total assets and increases healthcare and life sciences exposure to approximately 32% of the portfolio, up from 14%. In the first quarter of 2026, the company funded $17.6 million in new and follow-on investments and recorded $19.0 million of portfolio repayments and realizations.
Runway Growth Finance Corp. and SWK Holdings Corporation filed a Supplement to their March 3, 2026 Proxy Statement/Prospectus that updates the merger economics and unaudited pro forma financials assuming the Mergers closed on December 31, 2025. The Supplement presents a comparative fees and expenses table showing pro forma total annual expenses of 17.14% (expressed as a percentage of net assets attributable to common stock) and total annual expenses as a percentage of gross assets of 7.62% for the Combined Company.
The Supplement discloses the estimated purchase price consideration: $168,291,000 cash purchase price plus a $9,000,000 parent contribution, $660,000 severance and $5,863,000 transaction costs (total cash consideration $183,814,000), plus $40,274,000 equity consideration, for a $224,088,000 total. A day-one purchase discount (unrealized gain) of $18,615,000 is recognized. Pro forma net assets are $552,858,000, pro forma common shares outstanding are 41,854,799, and pro forma NAV per share is $13.21.
Runway Growth Finance Corp. filed Post-Effective Amendment No. 1 to its Form N-14 registration statement to furnish exhibits, and the amendment becomes effective immediately upon filing pursuant to Rule 462(d). The amendment only adds exhibit materials and does not modify other parts of the registration statement.
The filing includes indemnification disclosures under Maryland law, confirms indemnification agreements with directors and officers, and lists a comprehensive exhibit index incorporating agreements, indentures, underwriting and credit‑facility amendments, consents and related documents by reference.
Runway Growth Finance Corp., a Maryland corporation listed on the Nasdaq Global Select Market, filed its annual report for the year ended December 31, 2025. The company trades under the symbol RWAY and also has 7.50% Notes due 2027 (RWAYL) and 7.25% Notes due 2031 (RWAYI) listed.
The report includes an extensive schedule of non‑affiliate and affiliate investments, primarily in senior secured debt, warrants and preferred or common equity across technology, healthcare, financial services, consumer and business services sectors. Many loans reference floating rates such as SOFR or PRIME with stated spreads, rate floors, and features like PIK interest and end‑of‑term payments.
Investments span companies such as Blueshift Labs, Marley Spoon, JobGet, CloudPay, FiscalNote, Madison Reed, Kin Insurance, Bombora, RealWear, Brivo and Gynesonics, with initial acquisition dates ranging from 2017 onward and maturities reaching into the early 2030s. The mix of senior secured term loans, revolvers, second‑lien positions, warrants and equity interests highlights a diversified, credit‑focused growth finance strategy.
Runway Growth Finance Corp. reported fourth-quarter 2025 total investment income of $30.0 million and net investment income of $11.6 million, or $0.32 per share. Net asset value was $485.0 million, or $13.42 per share, and the investment portfolio stood at $927.4 million across 56 companies.
For full-year 2025, the company generated $137.3 million of total investment income and $56.9 million of net investment income, or $1.55 per share$0.33 per share and reported an average gross credit loss ratio of just 10 basis points since inception, highlighting relatively modest realized credit losses.
Runway Growth also refinanced part of its balance sheet. It repaid its 8.54% April 2026 notes in January 2026, issued $103.25 million of 7.25% unsecured notes due 2031 in February 2026, and redeemed portions of its 2027 notes in March 2026, while maintaining available liquidity of $395.2 million as of December 31, 2025.
Runway Growth Finance Corp. has a class of debt securities, the 8.00% Notes due 2027, removed from listing and/or registration on the Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act. Nasdaq states it and the issuer complied with the Exchange's rules and with the voluntary withdrawal procedures in 17 CFR 240.12d2-2(c).
SWK Holdings Corporation seeks stockholder approval to merge into Runway Growth Finance Corp. through a three-step transaction, subject to SWK stockholder vote at a virtual special meeting on March 31, 2026. Each SWK share will convert, at holder election, into Per Share Stock Consideration (shares of RWAY) or Per Share Cash Consideration (equal to SWK Per Share NAV), plus a pro rata portion of a $9,000,000 guaranteed cash payment from the Adviser. The Exchange Ratio is the quotient of SWK Per Share NAV divided by RWAY Per Share NAV, both calculated within two business days prior to closing and rounded to four decimals. As of the record date March 2, 2026, there were 12,095,906 shares of SWK Common Stock outstanding. The SWK Board unanimously recommends a vote FOR the proposals.
Runway Growth Finance Corp. announced that its board of directors has declared a first quarter 2026 cash dividend of $0.33 per share. Stockholders of record at the close of business on March 10, 2026 will be entitled to receive this distribution.
The dividend is scheduled to be paid on or about March 24, 2026. Runway Growth generally intends to distribute substantially all of its available earnings on a quarterly basis, subject to board discretion, regulatory requirements, and its financial condition. Dividends are automatically reinvested for stockholders who do not opt out of the company’s dividend reinvestment plan.